Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mihaela Poroch has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serological Biomarkers, Echocardiographic Indices, and Patient-Reported Outcomes in Advanced Heart Failure: A Systematic Review and Meta-Analysis Informing Palliative and Advanced-Therapy Decision-Making

    by Tatiana Dramba, Alin Constantin Pînzariu, Ana-Maria Casapu, Mihaela Poroch, Eliza-Maria Armeanu, Andrei-Emilian Popa, Elena Popa, Gema Bacoanu, Elena-Andreea Moales, Cringuta Mariana Paraschiv, et al.

    Background/Objectives: Advanced heart failure (HF) carries a high symptom burden and mortality, and identifying the right time for palliative and advanced-therapy discussions remains difficult. We systematically reviewed the prognostic value of serological biomarkers, echocardiographic indices, and patient-reported outcomes (PROs) in advanced HF. Methods: PubMed, Scopus, Web of Science, and the Cochrane Library were searched on 1 June 2026 for studies published within the prior 10 years, following PRISMA 2020 (PROSPERO CRD420261505929). Risk of bias was assessed with the Newcastle–Ottawa Scale and certainty of evidence with GRADE. Hazard ratios (HRs) for all-cause mortality were pooled with random-effects models within pathophysiologically defined serological subgroups; markers with opposing prognostic directions were synthesized narratively. Results: Of 3866 records, 37 studies (approximately 31,849 patients) were included; 29 (78%) were at low risk of bias. The pooled HR was 1.35 (95% CI 1.06–1.74; k = 4; I2 = 92%) for neurohormonal/congestive markers; exploratory two-study estimates were 1.75 (1.50–2.04; I2 = 6%) for renal/cardiorenal and 2.17 (0.85–5.52; I2 = 86%) for inflammatory-nutritional markers. GRADE certainty was Low for the renal/cardiorenal estimate and Very Low for the other two, and funnel-plot asymmetry suggested small-study effects. Echocardiographic and PRO markers were individually associated with prognosis but showed opposing directions within outcome categories and were not pooled. Conclusions: Serological, echocardiographic, and patient-reported markers each carry prognostic information in advanced HF, but the pooled estimates are exploratory. Most studies assessed mortality or hospitalization rather than palliative or advanced-therapy decisions; relevance to such decisions is interpretive and requires prospective confirmation.

  • Open Access

    SGLT2 Inhibition Combined with Zn Supplementation Protects the Liver-Pancreas Axis in Experimental Type 2 Diabetes

    by Irina Claudia Anton, Carmen Solcan, Liliana Mititelu-Tartau, Cornelia Amalinei, Mihaela Poroch, Vladimir Poroch, Beatrice Rozalina Buca, Cosmin-Gabriel Tartau, Ana-Maria Pelin, Alexandra Jitareanu, et al.

    Type 2 diabetes mellitus (T2DM) is associated with chronic hyperglycemia, inflammation, and progressive hepatic and pancreatic dysfunction. Although sodium-glucose cotransporter 2 (SGLT2) inhibitors exert metabolic and organ-protective effects, their ability to preserve pancreatic architecture and attenuate diabetes-associated hepatic injury, particularly combined with nutritional interventions, remains insufficiently explored. This study investigated the protective effects of dapagliflozin (DAPA) and empagliflozin (EMPA), alone or combined with zinc (Zn), on hepatic and pancreatic alterations in experimental diabetes. Methods: Diabetes was induced in male Sprague–Dawley rats using streptozotocin (STZ) and high fat diet (HFD). Diabetic animals received DAPA, EMPA, Zn, or SGLT2 inhibitor–Zn combinations for four weeks. Hepatic biochemical parameters, lipid profile, histopathology, pancreatic morphometry, and insulin immunoreactivity were evaluated. Diabetes induced hepatic and pancreatic alterations, including elevated liver injury markers, hepatocellular degeneration, reduced islet number and β-cell density, and diminished insulin immunoreactivity. DAPA and EMPA attenuated these changes, with greater improvements following Zn combination therapy. EMPA + Zn produced the most favorable response, improving hepatic architecture, reducing VCAM-1, ICAM-1, and NF-κB expression, preserving islet morphology, increasing β-cell density, and enhancing insulin immunoreactivity. SGLT2 inhibitors attenuated diabetes-associated hepatic and pancreatic alterations in this experimental model, while Zn supplementation was associated with additional tissue-preserving effects, particularly when combined with EMPA. These findings support further investigation of combined SGLT2 inhibition and Zn supplementation as an experimental approach to diabetes-associated organ injury; however, their clinical relevance remains to be established.

  • Open Access

    Score Distributions of the Mini-Mental State Examination, Clock Drawing Test, and Reisberg Global Deterioration Scale Across Operational Cognitive Impairment Severity Strata in Romanian Primary Care: A Cross-Sectional Descriptive Study

    by Elena Popa, Raluca Ecaterina Haliga, Eric Oliviu CoșOvanu, Carmen Liliana Barbacariu, Monica Iuliana Ungureanu, Mihaela Poroch, Mihaela Roxana Barbu, Elena Adorata Coman

    Background/Objectives: The Mini-Mental State Examination (MMSE), Clock Drawing Test (CDT), and Reisberg Global Deterioration Scale (GDS) are used together in primary care. This study describes their score distributions across operational severity strata in a Romanian cohort. Methods: We conducted a cross-sectional descriptive study of a selected cohort of 326 adults aged ≥50 years with suspected cognitive impairment in three family medicine practices in Iași. One unblinded clinician administered all instruments and assigned the strata by integrated clinical assessment of functional status, MMSE performance, and Reisberg GDS staging, with approximate reference bands for both scales. Scores and their positions relative to these bands were summarised descriptively. Results: The strata comprised 53 participants with mild, 247 with moderate, and 26 with severe cognitive impairment; 39.3% of participants were illiterate or had ≤4 years of schooling. Cohort medians (ranges) were 15 (0–25) for the MMSE, 4 (0–10) for the CDT, and 5 (1–7) for the Reisberg GDS. In the mild and moderate strata, respectively, 30.2% and 30.0% of MMSE scores and 26.4% and 27.5% of Reisberg stages lay outside the approximate reference bands. Conclusions: Because MMSE and Reisberg information contributed to the classification, the assessor was not blinded, and the severe stratum was small, these descriptive results cannot establish diagnostic discrimination or comparative measurement performance.

  • Open Access

    GLP-1, GIP, and Glucagon Receptor Agonism at the Obesity–Neurodegeneration Interface: A Narrative Review

    by Elena Popa, Andrei Emilian Popa, Vladimir Poroch, Thomas Gabriel Schreiner, Ana Maria Slanina, Mihaela Poroch, Alexandru Matei Hatneanu, Monica Iuliana Ungureanu, Antoneta Dacia Petroaie, Agnes Iacinta Bacusca, et al.

    Glucagon-like peptide-1 receptor agonism has attracted interest in neurodegeneration because of its effects on metabolic and inflammatory pathways implicated in neuronal dysfunction. This narrative review examines the molecular rationale and neurological evidence for selective glucagon-like peptide-1 receptor agonists, dual agonists additionally targeting the glucose-dependent insulinotropic polypeptide receptor, and triple agonists also engaging the glucagon receptor. English-language literature retrieved from PubMed, Scopus, and Web of Science was synthesized according to study design and neurological relevance. Preclinical findings indicate modulation of insulin signaling, synaptic function, mitochondrial homeostasis, and neuroinflammation, but responses vary across compounds and experimental models. In Alzheimer’s disease, liraglutide did not meet its primary trial endpoint, and semaglutide did not slow clinical progression. Parkinson’s disease trials have yielded mixed results without establishing disease modification. Observational associations with reduced dementia risk remain susceptible to confounding. Neurological evidence for tirzepatide and retatrutide remains predominantly observational or preclinical. Greater metabolic efficacy does not establish neuroprotection, while nutritional vulnerability may constrain therapeutic applicability. Dedicated randomized trials integrating clinical outcomes with pharmacological exposure, target engagement, and metabolic mediation are required to distinguish systemic effects from direct neural actions and determine whether these therapies can prevent cognitive decline or modify established neurodegenerative disease.

  • Open Access

    Biological Profile of Ferulic Acid-Based Thiazolidin-4-One Derivatives: Toxicity, Inflammation, and Oxidative Stress Biomarkers

    by Maria Dragan, Andreea-Teodora Iacob, Cornelia Mircea, Catalina Daniela Stan, Oana-Maria Dragostin, Alin-Viorel FocșA, Diana Tatarciuc, Ruxandra-Teodora Stan, Mihaela Poroch, Lenuta Profire

    Since inflammation is a fundamental process involved in tissue injury and repair, the evaluation of the anti-inflammatory potential of novel compounds is of considerable importance. Acute toxicity evaluation in Swiss albino mice revealed that the synthesized thiazolidin-4-one derivatives of ferulic acid possess moderate toxicity. The in vivo biological activity of synthesized thiazolidin-4-one derivatives (1a–j) was assessed through a model of acute inflammation induced by carrageenan in rats and in a chronic inflammation model induced in rats using the granuloma test. The compounds exhibited significant anti-inflammatory effects, with maximum activity observed 24 h after administration, suggesting a prolonged duration of action. In the acute inflammation model, compound 1g exhibited the highest anti-inflammatory activity, achieving 97.43% inhibition of inflammatory edema after 24 h. In the chronic inflammation model, all derivatives reduced granulation tissue formation, indicating inhibition of the proliferative component of inflammation, with compound 1e showing the highest inhibition (79.85%). Safety evaluation was complemented by biochemical and hematological investigations performed on blood samples collected from the experimental animals. Hepatic function was assessed by measuring serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT), together with renal and hematological parameters, revealing no significant toxicity. In addition, biochemical analysis of liver homogenates demonstrated modulation of oxidative stress markers, including malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT) activities, indicating that the investigated thiazolidin-4-one derivatives do not induce marked oxidative imbalance under the experimental conditions. Overall, compound 1g emerged as the most promising derivative based on its balanced anti-inflammatory efficacy and favorable oxidative stress profile.

  • Open Access

    Magnesium Status in Celiac Disease: Potential Links with Neuroinflammatory Pathways and Gut–Brain Axis Dysfunction

    by Elena Popa, Andrei Emilian Popa, Mihaela Poroch, Vladimir Poroch, Alexandru Matei Hatneanu, Ana-Maria Slanina, Monica Iuliana Ungureanu, Tatiana Dramba, Antoneta Dacia Petroaie, Agnes Iacinta Bacusca, et al.

    Celiac disease (CD) is a chronic immune-mediated enteropathy characterized by intestinal inflammation, epithelial barrier dysfunction, and a wide range of extraintestinal manifestations, including neurological disorders. Magnesium (Mg) status has attracted increasing interest because Mg is involved in inflammatory regulation, oxidative balance, mitochondrial function, calcium homeostasis, and neuronal signaling, suggesting a potential role in neuroimmune pathways and gut–brain axis communication. This narrative review critically evaluates the available evidence regarding the relationship between Mg status, neuroinflammation, and gut–brain axis dysfunction in CD. A literature search was performed using PubMed, Scopus, and Web of Science, focusing primarily on studies published between 2019 and 2025, while earlier landmark publications were included to provide mechanistic context. The review was conducted according to the Scale for the Assessment of Narrative Review Articles (SANRA). Current evidence indicates that reduced Mg status in CD is primarily associated with intestinal malabsorption, chronic inflammation, and dietary inadequacies. Experimental and translational studies support several mechanisms through which Mg may influence neuroimmune signaling; however, clinical evidence directly linking altered Mg status to neurological manifestations in patients with CD remains limited. Overall, Mg should be regarded as a potential modifier of inflammatory and neuroimmune pathways rather than an independent pathogenic factor. Further prospective studies are needed to clarify the contribution of Mg homeostasis to neurological manifestations in CD.

  • Open Access

    Zinc Potentiates the Renoprotective Effects of SGLT2 Inhibitors in Experimental Diabetes Mellitus in Rats

    by Irina Claudia Anton, Carmen Solcan, Liliana Mititelu Tartau, Cornelia Amalinei, Mihaela Poroch, Vladimir Poroch, Beatrice Rozalina Buca, Cosmin-Gabriel Tartau, Ana-Maria Pelin, Gina Eosefina Botnariu

    Background: Diabetic kidney disease is a common and serious complication of type 2 diabetes mellitus (T2DM) and represents a major contributor to chronic kidney disease (CKD) globally. While sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated significant renoprotective effects, the potential advantages of combining these agents with micronutrients such as zinc (Zn), known for its antioxidant, anti-inflammatory, and metabolic regulatory properties, have not been fully investigated. This study aimed to assess the effects of dapagliflozin (DAPA) and empagliflozin (EMPA), administered either alone or alongside Zn, in an experimental diabetes model. Methods: T2DM was induced in Sprague-Dawley rats through a high-fat diet (HFD) followed by a low dose of streptozotocin (STZ). Seven experimental groups were established: a control group, an untreated diabetic group, and treatment groups receiving DAPA, EMPA, or their combinations with Zn. Metabolic parameters, renal function, and histopathological alterations were assessed, while immunohistochemistry was used to evaluate the expression of inflammatory and fibrotic markers. Results: Diabetic rats exhibited sustained hyperglycemia, metabolic imbalance, and significant renal damage, accompanied by elevated levels of inflammatory and fibrotic markers. Treatment with SGLT2 inhibitors improved metabolic status, mitigated kidney injury, and reduced inflammatory marker expression. Zn association further potentiated these effects, with the most pronounced benefits observed when combined with EMPA. Conclusions: These findings suggest that SGLT2 inhibitors exert strong renoprotective effects in experimental diabetic nephropathy. Zn supplementation may amplify these benefits through its antioxidant and anti-inflammatory actions. The combination of EMPA and Zn demonstrated the greatest protective effect, highlighting the potential of multi-target therapeutic strategies in diabetic kidney disease.


  • Open Access

    Integrating Psychoneuroimmunological Factors into AI-Driven Risk Stratification for Cervical Intraepithelial Neoplasia:A Mixed Bibliometric and Empirical Study from Northern Romania Focusing on Depression and Anxiety

    by Ecaterina Tomaziu Todosia (Anton), Gabriel Dăscălescu, Alin Ciobica, Cristina Albert, Mihaela Tomaziu Todosia, Ioana Sadiye Scripcariu, Mihaela Poroch, Gabriel Ioan Anton, Cristian Bucsineanu, Demetra Gabriela Socolov

    Cervical intraepithelial neoplasia (CIN) is a multifactorial pathology mainly determined by persistent infection with high-risk human papillomavirus (HPV) genotypes and modulated by both immunological and psychological factors. This mixed bibliometric and empirical study integrates psychoneuroimmunological concepts with clinical data from a cohort of 150 patients (aged 18–55 years) from northern Romania. Seventy percent tested positive for high-risk HPV by self-sampling and all completed the PHQ-9 and GAD-7 scales that were subsequently assessed. Symptoms of depression and anxiety were prevalent, with anxiety being reported by 43% of participants who performed self-sampling at home.Fifty women with cytologically diagnosed HSIL underwent a comparative evaluation using both, classical colposcopy and the artificial intelligence-assisted EVA system (MobileODT, Israel). Artificial intelligence-based colposcopy demonstrated higher sensitivity (92% versus 82%) and higher diagnostic concordance (88%) with histopathological confirmation, suggesting superior accuracy and clinical feasibility.These results support the integration of psychoneuroimmunological and artificial intelligence-assisted diagnostic parameters into cervical cancer prevention frameworks, highlighting the importance through which artificial intelligence could complement neoplasia prevention, addressing psychological profile and biological markers to improve personalised risk stratification.


  • Open Access

    Palliative Care in Chronic Heart Failure: A Systematic Review of Its Impact on Symptoms, Quality of Life, and Decision-Making Process

    by Tatiana Dramba, Andrei-Emilian Popa, Mihaela Poroch, Gema Bacoanu, Irina Mihaela Esanu, Elena Popa, Vladimir Poroch

    Background: Palliative care has emerged as a key component in the management of chronic heart failure, addressing persistent physical and psychosocial symptoms that often remain insufficiently controlled by conventional cardiology. This systematic review aimed to evaluate the impact of palliative care interventions on symptom burden, quality of life (QoL) and decision-making processes in adults with chronic heart failure. Methods: A systematic search of PubMed, Scopus and Web of Science identified studies published between January 2005 and February 2025. Eligible designs included randomized controlled trials, observational cohorts and qualitative studies. The review followed PRISMA 2020 guidelines. Methodological quality was assessed using the Cochrane Risk of Bias 2.0 (RoB 2.0), Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I) and Joanna Briggs Institute (JBI) appraisal tools. Due to heterogeneity in study designs and outcomes, a narrative synthesis was conducted. Results: Nineteen studies met the inclusion criteria. Palliative care interventions consistently reduced dyspnea, fatigue, anxiety and depression and were associated with improved functional status and QoL. Integrated palliative–cardiology programs were linked to fewer hospital readmissions, shorter hospital stays and increased documentation of advance care planning. However, methodological variability, small sample sizes and non-standardized outcome measures limited comparability across studies. Conclusions: The evidence supports the early incorporation of palliative care into routine management of chronic heart failure. Early, multidisciplinary and patient-centered approaches enhance clinical and psychosocial outcomes while improving healthcare efficiency and ensuring that care aligns with patients’ goals, values and quality-of-life priorities.


  • Open Access

    Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review

    by Andrei Emilian Popa, Elena Popa, Tatiana Dramba, Elena Adorata Coman, Mihaela Poroch, Monica Ungureanu, Agnes Bacusca, Ana Maria Slanina, Gema Bacoanu, Vladimir Poroch

    Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.